Immunospecific targeting of CD45 expressing lymphoid cells: Towards improved detection agents of the sentinel lymph node

Cancer Letters

Volumn 328, Issue 2, 2013, Pages 271-277

  Liu, Tianqing ^a   Cousins, Aidan ^a   Chien, Chia Chi ^b   Kempson, Ivan ^b   Thompson, Sarah ^c   Hwu, Yeukuang ^b   Thierry, Benjamin ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b INSTITUTE OF PHYSICS   (Taiwan)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Anti CD45 immunotargeting; Gold nanoparticles; Lymphatic transport; Sentinel lymph node

Indexed keywords

CD45 ANTIGEN; CONTRAST MEDIUM; GOLD NANOPARTICLE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD45; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; AXILLARY LYMPH NODE; BINDING AFFINITY; CHEMICAL ANALYSIS; CONTROLLED STUDY; DRUG BINDING SITE; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG RETENTION; DRUG TARGETING; DRUG TRANSPORT; DRUG UPTAKE; FORELIMB; LYMPHOID CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENTINEL LYMPH NODE;

ANIMALS; ANTIGENS, CD45; CONTRAST MEDIA; IMMUNOCONJUGATES; LYMPH NODES; LYMPHOCYTES; METAL NANOPARTICLES; MICE; MICE, INBRED BALB C; PROTEIN BINDING;

MUS;

EID: 84870332138     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2012.09.024     Document Type: Article

References (34)

1. Kawada K., Taketo M.M. Significance and mechanism of lymph node metastasis in cancer progression. Cancer Res. 2011, 71:1214-1218.
2. van Akkooi A.C.J., Verhoef C., Eggermont A.M.M. Importance of tumor load in the sentinel node in melanoma: clinical dilemmas. Nat. Rev. Clin. Oncol. 2010, 7:446-454.
3. 99mTc-labeled and unlabeled antimony trisulfide and rhenium sulfide colloids intended for lymphoscintigraphic application. J. Nucl. Med. 2001, 42:460-466.
4. Wang Z., Dong Z.-Y., Chen J.-Q., Liu J.-L. Diagnostic value of sentinel lymph node biopsy in gastric cancer: a meta-analysis. Ann. Surg. Oncol. 2012, 19:1541-1550.
5. Thompson S., Bartholomeusz D., Jamieson G. Sentinel lymph node biopsy in esophageal cancer: should it be standard of care?. J. Gastrointest. Surg. 2011, 15:1762-1768.
6. van de Ven C., De Leyn P., Coosemans W., Van Raemdonck D., Lerut T. Three-field lymphadenectomy and pattern of lymph node spread in T3 adenocarcinoma of the distal esophagus and the gastro-esophageal junction. Eur. J. Cardiothorac. Surg. 1999, 15:769-773.
7. Karim R.Z., Scolyer R.A., Li W., Yee V.S.K., McKinnon J.G., Li L.-X.L., Uren R.F., Lam S., Beavis A., Dawson M., Doble P., Hoon D.S.B., Thompson J.F. False negative sentinel lymph node biopsies in melanoma may result from deficiencies in nuclear medicine, surgery, or pathology. Ann. Surg. 2008, 247:1003-1010.
8. Weissleder R., Pittet M.J. Imaging in the era of molecular oncology. Nature 2008, 452:580-589.
9. Choi H.S., Frangioni J.V. Nanoparticles for biomedical imaging: fundamentals of clinical translation. Mol. Imaging 2010, 9:291-310.
10. Harisinghani M.G., Barentsz J., Hahn P.F., Deserno W.M., Tabatabaei S., van de Kaa C.H., de la Rosette J., Weissleder R. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N. Engl. J. Med. 2003, 348:2491-2499.
11. Rabin O., Perez J.M., Grimm J., Wojtkiewicz G., Weissleder R. An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles. Nat. Mater. 2006, 5:118-122.
12. Dayton P.A., Rychak J.J. Molecular ultrasound imaging using microbubble contrast agents. Front. Biosci. 2007, 12:5124-5142.
13. Hahn M., Singh A., Sharma P., Brown S., Moudgil B. Nanoparticles as contrast agents for in vivo bioimaging: current status and future perspectives. Anal. Bioanal. Chem. 2011, 399:3-27.
14. Pan D., Pramanik M., Senpan A., Ghosh S., Wickline S.A., Wang L.V., Lanza G.M. Near infrared photoacoustic detection of sentinel lymph nodes with gold nanobeacons. Biomaterials 2010, 31:4088-4093.
15. Tanaka E., Choi H., Fujii H., Bawendi M., Frangioni J. Image-guided oncologic surgery using invisible light: completed pre-clinical development for sentinel lymph node mapping. Ann. Surg. Oncol. 2006, 13:1671-1681.
16. Leong S., Kim J., Ross M., Faries M., Scoggins C., Rich Metz W., Cope F., Orahood R. A phase 2 study of (99m)Tc-tilmanocept in the detection of sentinel lymph nodes in melanoma and breast cancer. Ann. Surg. Oncol. 2011, 18:961-969.
17. Wallace A., Hoh C., Ellner S., Darrah D., Schulteis G., Vera D. Lymphoseek: a molecular imaging agent for melanoma sentinel lymph node mapping. Ann. Surg. Oncol. 2007, 14:913-921.
18. Phillips M.A., Gran M.L., Peppas N.A. Targeted nanodelivery of drugs and diagnostics. Nano Today 2010, 5:143-159.
19. Ocampo-García B.E., Ramírez F.d.M., Ferro-Flores G., De León-Rodríguez L.M., Santos-Cuevas C.L., Morales-Avila E., de Murphy C.A., Pedraza-López M., Medina L.A., Camacho-López M.A. 99mTc-labelled gold nanoparticles capped with HYNIC-peptide/mannose for sentinel lymph node detection. Nucl. Med. Biol. 2011, 38:1-11.
20. Thierry B., Griesser H.J. Dense PEG layers for efficient immunotargeting of nanoparticles to cancer cells. J. Mater. Chem. 2012, 22:8810-8819.
21. Klein S., Petersen S., Taylor U., Rath D., Barcikowski S. Quantitative visualization of colloidal and intracellular gold nanoparticles by confocal microscopy. J. Biomed. Opt. 2010, 15:036015.
22. Taylor U., Klein S., Petersen S., Kues W., Barcikowski S., Rath D. Nonendosomal cellular uptake of ligand-free, positively charged gold nanoparticles. Cytometry Part A 2010, 77A:439-446.
23. Pissuwan D., Niidome T., Cortie M.B. The forthcoming applications of gold nanoparticles in drug and gene delivery systems. J. Control Release 2011, 149:65-71.
24. Reddy S.T., Rehor A., Schmoekel H.G., Hubbell J.A., Swartz M.A. In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles. J. Control Release 2006, 112:26-34.
25. Ji R.-C. Lymphatic endothelial cells, tumor lymphangiogenesis and metastasis: new insights into intratumoral and peritumoral lymphatics. Cancer Metastasis Rev. 2006, 25:677-694.
26. Swartz M.A., Hubbell J.A., Reddy S.T. Lymphatic drainage function and its immunological implications: from dendritic cell homing to vaccine design. Semin. Immunol. 2008, 20:147-156.
27. Eck W., Craig G., Sigdel A., Ritter G., Old L.J., Tang L., Brennan M.F., Allen P.J., Mason M.D. PEGylated gold nanoparticles conjugated to monoclonal F19 antibodies as targeted labeling agents for human pancreatic carcinoma tissue. ACS Nano 2008, 2:2263-2272.
28. Eck W., Nicholson A.I., Zentgraf H., Semmler W., Bartling S.n. Anti-CD4-targeted gold nanoparticles induce specific contrast enhancement of peripheral lymph nodes in X-ray computed tomography of live mice. Nano Lett. 2010, 10:2318-2322.
29. Tsai S.-W., Chen Y.-Y., Liaw J.-W. Compound cellular imaging of laser scanning confocal microscopy by using gold nanoparticles and dyes. Sensors 2008, 8:2306-2316.
30. Wang S.-H., Lee C.-W., Chiou A., Wei P.-K. Size-dependent endocytosis of gold nanoparticles studied by three-dimensional mapping of plasmonic scattering images. J. Nanobiotechnol. 2010, 8:33.
31. Walkey C.D., Olsen J.B., Guo H., Emili A., Chan W.C.W. Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. J. Am. Chem. Soc. 2011, 134:2139-2147.
32. Harrell M.I., Iritani B.M., Ruddell A. Lymph node mapping in the mouse. J. Immunol. Methods 2008, 332:170-174.
33. Wallace A.M., Hoh C.K., Limmer K.K., Darrah D.D., Schulteis G., Vera D.R. Sentinel lymph node accumulation of Lymphoseek and Tc-99m-sulfur colloid using a "2-day" protocol. Nucl. Med. Biol. 2009, 36:687-692.
34. Moghimi S.M. The effect of methoxy-PEG chain length and molecular architecture on lymph node targeting of immuno-PEG liposomes. Biomaterials 2006, 27:136-144.